ESC: Pfizer, BMS’ Eliquis tops Xarelto, vitamin K drugs for site-specific bleeding risks in French real-world study

ESC: Pfizer, BMS’ Eliquis tops Xarelto, vitamin K drugs for site-specific bleeding risks in French real-world study
kblankenship
Sat, 08/29/2020 – 12:26